Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

The goal of this Funding Opportunity Announcement (FOA) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic drug...

This page is a Member Feature!

Our funder profiles contain contact information, application deadlines, eligibility requirements, financial information, and more.

You can view a sample funder profile.

Log in or join to become a Member today!

Note: If you access GrantStation through a partner, log in through their website first, and then follow the link to GrantStation. Then refresh this page to view this content.